Tranexamic Acid in Hip and Knee Arthroplasty
- PMID:26493971
- DOI: 10.5435/JAAOS-D-14-00223
Tranexamic Acid in Hip and Knee Arthroplasty
Abstract
Perioperative blood loss is a significant concern for patients undergoing total joint arthroplasty. A growing body of evidence has shown tranexamic acid (TXA) to be effective in decreasing perioperative blood loss and transfusion requirements in both primary and revision hip and knee arthroplasty. TXA is a synthetic drug that limits blood loss through inhibition of fibrinolysis and clot degradation. Both topical and intravenous administration of TXA, in a variety of dosing regimens, has proven effective. Further investigation is required to determine the optimal dose and dosing regimens; however, evidence exists to recommend an initial intravenous dose be given before beginning the procedure, with at least one additional intravenous dose administered postoperatively. Additionally, topical TXA doses >2 g appear to be more efficacious than lower doses. Finally, relatively few adverse reactions have been reported in arthroplasty patients, and no study to date has demonstrated an increased risk of symptomatic venous thromboembolic events in this patient population.
Keywords: Tranexamic acid; hip arthroplasty; knee arthroplasty.
Copyright 2015 by the American Academy of Orthopaedic Surgeons.
Comment in
- Tranexamic Acid in Hip and Knee Arthroplasty.Anand A, Melvin JS.Anand A, et al.J Am Acad Orthop Surg. 2016 Jun;24(6):e59. doi: 10.5435/JAAOS-D-15-00708.J Am Acad Orthop Surg. 2016.PMID:27135795No abstract available.
Similar articles
- Tranexamic acid or epsilon-aminocaproic acid in total joint arthroplasty? A randomized controlled trial.Bradley KE, Ryan SP, Penrose CT, Grant SA, Wellman SS, Attarian DE, Green CL, Risoli T Jr, Bolognesi MP.Bradley KE, et al.Bone Joint J. 2019 Sep;101-B(9):1093-1099. doi: 10.1302/0301-620X.101B9.BJJ-2018-1096.R1.Bone Joint J. 2019.PMID:31474134Clinical Trial.
- Cost benefit analysis of topical tranexamic acid in primary total hip and knee arthroplasty.Tuttle JR, Ritterman SA, Cassidy DB, Anazonwu WA, Froehlich JA, Rubin LE.Tuttle JR, et al.J Arthroplasty. 2014 Aug;29(8):1512-5. doi: 10.1016/j.arth.2014.01.031. Epub 2014 Feb 3.J Arthroplasty. 2014.PMID:24630599
- Blood loss and cost-effectiveness of oral vs intravenous tranexamic acid in primary total hip arthroplasty: A randomized clinical trial.Wu Y, Zeng Y, Hu Q, Li M, Bao X, Zhong J, Shen B.Wu Y, et al.Thromb Res. 2018 Nov;171:143-148. doi: 10.1016/j.thromres.2018.10.006. Epub 2018 Oct 6.Thromb Res. 2018.PMID:30312799Clinical Trial.
- Epsilon-aminocaproic acid versus tranexamic acid in total knee arthroplasty: a meta-analysis study.Riaz O, Aqil A, Asmar S, Vanker R, Hahnel J, Brew C, Grogan R, Radcliffe G.Riaz O, et al.J Orthop Traumatol. 2019 Jul 18;20(1):28. doi: 10.1186/s10195-019-0534-2.J Orthop Traumatol. 2019.PMID:31321578Free PMC article.Review.
- A systematic review and meta-analysis of the topical administration of tranexamic acid in total hip and knee replacement.Alshryda S, Sukeik M, Sarda P, Blenkinsopp J, Haddad FS, Mason JM.Alshryda S, et al.Bone Joint J. 2014 Aug;96-B(8):1005-15. doi: 10.1302/0301-620X.96B8.33745.Bone Joint J. 2014.PMID:25086114Review.
Cited by
- The use of tranexamic acid in open elbow release surgery.Goyal N, Wilson DJ, Wysocki RW, Fernandez JJ, Cohen MS.Goyal N, et al.Shoulder Elbow. 2022 Apr;14(2):189-193. doi: 10.1177/1758573220976055. Epub 2020 Dec 6.Shoulder Elbow. 2022.PMID:35265185Free PMC article.
- Efficacy and Systemic Absorption of Peri-articular Versus Intra-articular Administration of Tranexamic Acid in Total Knee Arthroplasty: A Prospective Randomized Controlled Trial.Pinsornsak P, Phunphakchit J, Boontanapibul K.Pinsornsak P, et al.Arthroplast Today. 2021 Aug 7;11:1-5. doi: 10.1016/j.artd.2021.06.005. eCollection 2021 Oct.Arthroplast Today. 2021.PMID:34401422Free PMC article.
- Navigating anemia and anticoagulation in elderly patients undergoing orthopedic surgery: strategies for preventing complications and implementing treatments.Grandone E, Tiscia GL, Ostuni A, Marongiu F, Barcellona D.Grandone E, et al.Blood Transfus. 2024 Sep;22(5):450-458. doi: 10.2450/BloodTransfus.640. Epub 2024 May 6.Blood Transfus. 2024.PMID:38814879Free PMC article.Review.
- Management of Blood Loss in Hip Arthroplasty: Korean Hip Society Current Consensus.Song JH, Park JW, Lee YK, Kim IS, Nho JH, Lee KJ, Park KK, Kim Y, Park JH, Han SB.Song JH, et al.Hip Pelvis. 2017 Jun;29(2):81-90. doi: 10.5371/hp.2017.29.2.81. Epub 2017 Jun 2.Hip Pelvis. 2017.PMID:28611958Free PMC article.Review.
- Fixation vs Arthroplasty for Femoral Neck Fracture in Patients Aged 40-59 Years: A Propensity-Score-Matched Analysis.Wilson JM, Jones CA, Holmes JS, Farley KX, Hernandez-Irizarry RC, Moore TJ Jr, Bradbury TL, Guild GN.Wilson JM, et al.Arthroplast Today. 2022 Mar 20;14:175-182. doi: 10.1016/j.artd.2021.10.019. eCollection 2022 Apr.Arthroplast Today. 2022.PMID:35342781Free PMC article.
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Medical